Janus Henderson Group PLC Revolution Medicines, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,590,727 shares of RVMD stock, worth $373 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
10,590,727
Previous 10,190,071
3.93%
Holding current value
$373 Million
Previous $360 Million
8.13%
% of portfolio
0.2%
Previous 0.21%
Shares
14 transactions
Others Institutions Holding RVMD
# of Institutions
330Shares Held
195MCall Options Held
890KPut Options Held
717K-
Vanguard Group Inc Valley Forge, PA15.8MShares$556 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$505 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$473 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$362 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY9.36MShares$330 Million3.49% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.09B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...